Regulatory Resources | DrND's Knowledge Hub™

PCI B.Pharm Syllabus 2026

The complete syllabus, published by the Pharmacy Council of India.

Full document

Bachelor of Pharmacy (B.Pharm) Syllabus 2026, as per NEP 2020

The regulation, curricular structure, all eight semesters, the list of electives and the laboratory specifications, proposed for the 2026–27 academic year. PDF, 358 pages, 4.3 MB.

Read online Download PDF

Publisher: Pharmacy Council of India. This is an unmodified copy of the file published on the PCI website (opens in a new tab), checked on 9 October 2026 and hosted here for convenience. PCI may revise its syllabus, so check PCI for the latest version.

Jump to a section

Numbers are PDF page numbers. Each link opens the syllabus in the reader on this site, at that page. The table of contents is on page 15. You can also open the original PDF in your browser.

Pharmacy education and regulations

From the Pharmacy Council of India.

Pharmacy Council of India (PCI) (opens in a new tab)
Notices, circulars, approved institutions and regulations from the statutory body for pharmacy education in India.
B.Pharm Syllabus 2026 on the PCI website (opens in a new tab)
PCI’s own page for the syllabus above.
Indian Knowledge System guidelines for B.Pharm (2026) (opens in a new tab)
PCI guidelines on integrating the Indian Knowledge System in the 2026 B.Pharm syllabus.
Education Regulations (opens in a new tab)
The Education Regulations of 1991 (with amendments) and 2020, as PDFs.
Course-wise regulations (opens in a new tab)
B.Pharm and M.Pharm regulations, Pharmacy Practice regulations, and the earlier B.Pharm and M.Pharm scheme and syllabus PDFs (implemented from 2016–17).
D.Pharm syllabus (Education Regulations 2020) (opens in a new tab)
The Diploma in Pharmacy syllabus and the list of prescribed equipment and apparatus.
Pharmacy Act, 1948 (opens in a new tab)
The Pharmacy Act and the regulations framed under it, as published by PCI.

Drugs, medicines and safety in India

Regulators and government bodies that publish drug laws, standards, price lists and treatment guidelines.

CDSCO (opens in a new tab)
The Central Drugs Standard Control Organisation, India’s national regulator for drugs, medical devices and clinical trials.
Drugs and Cosmetics Act and Rules (opens in a new tab)
The Drugs and Cosmetics Act, 1940, Drugs Rules, 1945, Medical Devices Rules, 2017, New Drugs and Clinical Trials Rules, 2019 and Cosmetics Rules, 2020.
Essential medicines (CDSCO) (opens in a new tab)
The National List of Essential Medicines 2022 and related lists, as PDFs.
List of banned drugs (opens in a new tab)
CDSCO’s list of banned drugs. The PDF listed on that page was released in January 2018, so check CDSCO notices for later changes.
Adverse drug reaction (ADR) reporting form (opens in a new tab)
The suspected ADR reporting form for healthcare professionals (PDF, 2 pages).
Indian Pharmacopoeia (opens in a new tab)
The Indian Pharmacopoeia Commission’s page for the Indian Pharmacopoeia, the official book of drug standards.
Pharmacovigilance Programme of India (PvPI) (opens in a new tab)
India’s programme for monitoring the safety of medicines, with ADR reporting, training and publications.
NPPA (opens in a new tab)
The National Pharmaceutical Pricing Authority, which handles drug price control and the Drugs (Prices Control) Order.
National List of Essential Medicines 2022 (opens in a new tab)
The NLEM 2022 as published by NPPA.
Standard Treatment Guidelines (opens in a new tab)
Standard treatment guidelines from the National Health Systems Resource Centre, Ministry of Health and Family Welfare.

International agencies and guidelines

Regulators such as the FDA and EMA, and international bodies such as WHO and ICH, whose databases and guidelines are free to use.

WHO Model Lists of Essential Medicines (opens in a new tab)
The World Health Organization’s essential medicines lists for adults and children.
WHO norms and standards for pharmaceuticals (opens in a new tab)
WHO guidance and specifications for pharmaceuticals.
Drugs@FDA (opens in a new tab)
A searchable database of FDA-approved drug products, with labels and approval history.
FDA Orange Book (opens in a new tab)
Approved drug products with therapeutic equivalence evaluations.
FDA drug guidances (opens in a new tab)
Guidance documents for drug developers and manufacturers.
EMA medicines (opens in a new tab)
The European Medicines Agency’s database of authorised medicines in the EU.
EMA scientific guidelines (opens in a new tab)
Scientific guidelines for human medicines.
ICH guidelines (opens in a new tab)
The International Council for Harmonisation’s quality, safety, efficacy and multidisciplinary guidelines.

All of these links open the agencies' own websites, which are outside DrND's Knowledge Hub. Their content, availability and web addresses are controlled by them and may change.